Cargando…
High-dose Botulinum Toxin Therapy: Safety, Benefit, and Endurance of Efficacy
BACKGROUND: Botulinum neurotoxin therapy (BoNT) is a powerful tool for treating many neurologic disorders. The U.S. Food and Drug Administration (FDA)-approved maximum onabotulinum toxin A (OnaA) dose is 400 units (U) per visit, but higher doses are commonly necessary, particularly when treating mul...
Autores principales: | Chiu, Shannon Y., Patel, Bhavana, Burns, Matthew R., Legacy, Joseph, Wagle Shukla, Aparna, Ramirez-Zamora, Adolfo, Deeb, Wissam, Malaty, Irene A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Columbia University Libraries/Information Services
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052428/ https://www.ncbi.nlm.nih.gov/pubmed/32149014 http://dx.doi.org/10.7916/tohm.v0.749 |
Ejemplares similares
-
Comparable Botulinum Toxin Outcomes between Primary and Secondary Blepharospasm: A Retrospective Analysis
por: Martinez-Ramirez, Daniel, et al.
Publicado: (2014) -
Occurrence of Dysphagia Following Botulinum Toxin Injection in Parkinsonism-related Cervical Dystonia: A Retrospective Study
por: Patterson, Addie, et al.
Publicado: (2016) -
Multidisciplinary Telemedicine Care for Tourette Syndrome: Minireview
por: Cen, Shan-shan, et al.
Publicado: (2020) -
Brain Atrophy Following Deep Brain Stimulation: Management of a Moving Target
por: Chiu, Shannon Y., et al.
Publicado: (2020) -
Benign tremulous Parkinsonism: a unique entity or another facet of Parkinson’s disease?
por: Deeb, Wissam, et al.
Publicado: (2016)